ResMed (RMD)
(Real Time Quote from BATS)
$214.22 USD
+1.34 (0.63%)
Updated May 9, 2024 10:16 AM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 1.99 |
EPS Last Quarter | 2.13 |
Last EPS Surprise | 10.94% |
ABR | 1.68 |
Earnings ESP
|
2.62% |
---|---|
Current Year | 7.59 |
Next Year | 8.58 |
EPS (TTM) | 7.25 |
P/E (F1) | 28.05 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.20B | 1.18B | 4.66B | 4.99B |
# of Estimates | 6 | 4 | 6 | 6 |
High Estimate | 1.23B | 1.19B | 4.69B | 5.09B |
Low Estimate | 1.19B | 1.18B | 4.62B | 4.90B |
Year ago Sales | 1.12B | 1.10B | 4.22B | 4.66B |
Year over Year Growth Est. | 7.35% | 7.25% | 10.38% | 7.06% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.99 | 2.02 | 7.59 | 8.58 |
# of Estimates | 5 | 3 | 6 | 6 |
Most Recent Consensus | 2.02 | 2.02 | 7.29 | 8.04 |
High Estimate | 2.11 | 2.09 | 7.77 | 9.29 |
Low Estimate | 1.90 | 1.94 | 7.29 | 8.04 |
Year ago EPS | 1.60 | 1.64 | 6.44 | 7.59 |
Year over Year Growth Est. | 24.38% | 23.17% | 17.86% | 13.04% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 2 | 4 | 4 |
Up Last 60 Days | 3 | 2 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | 1.99 | 2.02 | 7.59 | 8.58 |
7 Days Ago | 1.99 | 2.02 | 7.59 | 8.58 |
30 Days Ago | 1.96 | 1.96 | 7.44 | 8.28 |
60 Days Ago | 1.96 | 1.96 | 7.43 | 8.22 |
90 Days Ago | 1.96 | 1.96 | 7.43 | 8.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.04 | 2.02 | 7.64 | 8.67 |
Zacks Consensus Estimate | 1.99 | 2.02 | 7.59 | 8.58 |
Earnings ESP | 2.62% | 0.00% | 0.69% | 1.10% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.13 | 1.88 | 1.64 | 1.60 | NA |
Estimate | 1.92 | 1.81 | 1.63 | 1.67 | NA |
Difference | 0.21 | 0.07 | 0.01 | -0.07 | 0.06 |
Surprise | 10.94% | 3.87% | 0.61% | -4.19% | 2.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more